REGENERON PHARMACEUTICALS, INC.
•CIK: 872589•Filing: Q4 2025
**REGENERON PHARMACEUTICALS, INC.** manages a focused $34M AUM across a concentrated two-position portfolio. The fund exhibits a significant overweighting in NTLA, representing $33.3M of its total assets. This structure indicates a high conviction thesis centered on the biotechnology sector, with a minor allocation to TORCEUR at $0.5M. The strategy is characterized by deep, single-name concentration within the pharmaceutical landscape.
Total AUM
$33.8M
QoQ Performance
-95.2%
Positions
2
Top 10 Concentration
100.0%
Latest Filing
Q4 2025
Top Holdings Allocation
NTLA
NTLA98.5%
TORCEUR1.5%
📈 Biggest Buys
No new positions or increases this quarter
📉 Biggest Sells
TORCEUR
Adicet Bio, Inc.
-93.8%
1.5% of portfolio
Sector Breakdown
Other100.0%
🚪 Exited Positionssold since Q3 2025
—
Adverum Biotechnologies, Inc.
SOLD
$819.5K
Changes from Q3 2025
↓1 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024